• About Us
  • Privacy Policy
  • Terms of Services
  • Contact
Tech News, Magazine & Review 2025
  • Home
  • About
  • Newsroom
  • FAQs
  • Submit Press Release
No Result
View All Result
My Account
  • Home
  • About
  • Newsroom
  • FAQs
  • Submit Press Release
No Result
View All Result
FirstPublisher
No Result
View All Result
Home Press Release

Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2

by News Desk
November 24, 2025
Lineus Medical Receives Patent for SafeBreak® Vascular Generation 2 - FirstPublisher.org
Share on FacebookShare on Twitter

FAYETTEVILLE, Ark. – Lineus Medical, the leader in vascular access innovation, has been awarded a U.S. patent for SafeBreak® Vascular Generation 2, the next evolution of the company’s flagship breakaway device. The newly patented design features a single-valve system, replacing the original device’s two-valve configuration. The ideas captured in the patent allow the device to have a significantly smaller profile while maintaining the device’s core function of protecting IV lines from damaging external forces by separating. The patent also includes the ability to add a light and/or sound notification for nurses when the device separates. The current version of SafeBreak relies on IV pump alarm to alert nurses of a separation. Having an alarm on SafeBreak will help open up the home healthcare and gravity line IV market for the company.

SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.¹ When a damaging force is placed on the line, SafeBreak intentionally separates to remove the force and protect the patient’s IV.   When separation occurs, valves on both ends of the device close to prevent medication leakage from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient’s infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money.1

“Lineus Medical continues to innovate and be the thought leader both clinically and scientifically in the breakaway device market,” said Vance Clement, CEO of Lineus Medical. “SafeBreak Gen 2 will move us closer to accomplishing our mission of removing the pains associated with IV lines for patients, nurses, and hospitals.”

“The SafeBreak Gen 2 design reflects our ongoing commitment to the continuous improvement of SafeBreak,” said Will Armstrong, COO of Lineus Medical. “This patent showcases how our engineering team is advancing breakaway device technology with smarter, simpler design solutions that improve patient care while further strengthening the company’s intellectual property portfolio.”

About Lineus Medical

Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.

References:

1. Data on file.

News Desk
News Desk

News Desk

Recommended.

May 2026 AliExpress Promo Codes Guide, Tested New AliExpress Coupon Codes, Vouchers and Discount Codes to Help You Go Through the Whole May

155
Casting Accountability Is Craft An Intentional Cultural Lens Framework — Paul Sinacore, CSA - FirstPublisher.org

Casting Accountability Is Craft: An Intentional Cultural Lens Framework — Paul Sinacore, CSA

155

Trending.

Best Crypto Trading Bots in 2026: How AI Automation Is Changing Digital Asset Trading

161
Pixel Web Solutions Redefines DEX Market with Scalable Uniswap Clone Development Services - FirstPublisher.org

Pixel Web Solutions Redefines DEX Market with Scalable Uniswap Clone Development Services

159

The 4th Season of the Top Trading Master Tournament Officially Begins

157

Anchored in the Asia-Pacific region, practicing inclusive finance: Noemon Finance’s 2026 global strategic upgrade reshapes the new paradigm of mass asset allocation.

157

TKROBOTS Introduces AI Quant Trading Bot to Make Automated Crypto Trading Easier for Everyday Users

156
  • About Us
  • Privacy Policy
  • Terms of Services
  • Contact
Telegram: @FirstPublisher

© 2025 Firstpublisher

No Result
View All Result
  • Home

© 2025 Firstpublisher